rheumatology
Pain

ARA says ‘no’ to medical cannabis

The Australian Rheumatology Association says it does not support the use of cannabinoids in routine clinical practice for the treatment of pain in arthritis and other musculoskeletal conditions. In a new position statement the ARA says there is only weak evidence of efficacy in patients using cannabinoids, and the marginal benefits may be outweighed by ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic